# FDA 483 - Ramy A. Fayad, M.D. - December 18, 2024

Source: https://www.globalkeysolutions.net/records/483/ramy-a-fayad-md/a64c6380-54a7-44bb-a07e-1a1900a638fd

> FDA 483 for Ramy A. Fayad, M.D. on December 18, 2024. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Ramy A. Fayad, M.D.
- Inspection Date: 2024-12-18
- Product Type: other
- Office Name: Cincinnati District Office
- Summary: An FDA inspection of Ramy A. Fayad, M.D. in Toledo, OH, identified a significant issue regarding the timely reporting of serious adverse events. The clinical investigator failed to adhere to protocol requirements for reporting an SAE, specifically a subject's hospitalization for pneumonia, within the specified timeframe. This indicates a lapse in adherence to clinical trial protocols for patient safety reporting.

## Related Officers

- [Brittany M. Kershaw](https://www.globalkeysolutions.net/people/brittany-m-kershaw/b0e79b65-9d6f-4f5d-8a60-1a32df8c1b61)

Company: https://www.globalkeysolutions.net/companies/ramy-a-fayad-md/ddfd067c-2a1d-4ca8-8929-a09aa53c4339

Office: https://www.globalkeysolutions.net/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22